You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Acute Pain Relief After Mantram Meditation in Children With Neuroblastoma Undergoing Anti-GD2 Monoclonal Antibody Therapy

Ahmed, Mahiuddin PhD; Modak, Shakeel MD; Sequeira, Sonia PhD

Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0000000000000024
Clinical and Laboratory Observations
Abstract

Nonpharmacologic, mind-body interventions are used to reduce anxiety in pediatric patients. Anti-ganglioside GD2 monoclonal antibody (anti-GD2 MoAb 3F8) therapy is the standard of care for high-risk neuroblastoma and pain is its major side effect. We performed a retrospective analysis of children undergoing anti-GD2 MoAb 3F8 treatment who received guided meditation. Meditation involved concentrating on the repetition of rhythmic, melodic sounds purported to slow breathing and induce a relaxation response. A total of 71% patients completed a session at first (n=19) or second attempt (n=5). Patients received fewer analgesic doses to manage anti-GD2 MoAb 3F8-induced pain when participating in meditation (n=17, mean=−0.4 dose, P<0.01). Mantram meditation is a feasible outpatient intervention associated with reduced analgesic requirements.

Author Information

*Department of Pediatrics

Office of Clinical Research, Memorial Sloan-Kettering Cancer Center, New York, NY

The authors declare no conflict of interest.

Reprints: Sonia Sequeira, PhD, Office of Clinical Research, Memorial Sloan-Kettering Cancer Center, New York, NY 10065 (e-mail: sequeirs@mskcc.org).

Received March 21, 2013

Accepted August 20, 2013

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.